Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis

Background: Isoniazid (INH) resistance in Mycobacterium tuberculosis has been mainly attributed to mutations in katG (64%) and inhA (19%). However, 20%–30% resistance to INH cannot be explained by mutations alone. Hence, other mechanisms besides mutations may play a significant role in providing dru...

Full description

Bibliographic Details
Main Authors: Anshika Narang, Astha Giri, Shraddha Gupta, Kushal Garima, Mridula Bose, Mandira Varma-Basil
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=177;epage=183;aulast=Narang
id doaj-f347d26031634bfa80df21bd9b4968cd
record_format Article
spelling doaj-f347d26031634bfa80df21bd9b4968cd2020-11-25T00:24:55ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2017-01-016217718310.4103/ijmy.ijmy_26_17Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosisAnshika NarangAstha GiriShraddha GuptaKushal GarimaMridula BoseMandira Varma-BasilBackground: Isoniazid (INH) resistance in Mycobacterium tuberculosis has been mainly attributed to mutations in katG (64%) and inhA (19%). However, 20%–30% resistance to INH cannot be explained by mutations alone. Hence, other mechanisms besides mutations may play a significant role in providing drug resistance. Here, we explored the role of 24 putative efflux pump genes conferring INH-resistance in M. tuberculosis. Materials and Methods: Real-time expression profiling of the efflux pump genes was performed in five INH-susceptible and six high-level INH-resistant clinical isolates of M. tuberculosis exposed to the drug. Isolates were also analyzed for mutations in katG and inhA. Results: Four high-level INH-resistant isolates (minimum inhibitory concentration [MIC] ≥2.5 mg/L) with mutations at codon 315 (AGC-ACC) of katG showed upregulation of one of the efflux genes Rv1634, Rv0849, efpA, or p55. Another high-level INH-resistant isolate (MIC 1.5 mg/L), with no mutations at katG or inhA overexpressed 8/24 efflux genes, namely, Rv1273c, Rv0194, Rv1634, Rv1250, Rv3823c, Rv0507, jefA, and p55. Five of these, namely, Rv0194, Rv1634, Rv1250, Rv0507, and p55 were induced only in resistant isolates. Conclusion: The high number of efflux genes overexpressed in an INH-resistant isolate with no known INH resistance associated mutations, suggests a role for efflux pumps in resistance to this antituberculous agent, with the role of Rv0194 and Rv0507 in INH resistance being reported for the first time.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=177;epage=183;aulast=NarangEfflux pumpsisoniazid resistanceMycobacterium tuberculosis
collection DOAJ
language English
format Article
sources DOAJ
author Anshika Narang
Astha Giri
Shraddha Gupta
Kushal Garima
Mridula Bose
Mandira Varma-Basil
spellingShingle Anshika Narang
Astha Giri
Shraddha Gupta
Kushal Garima
Mridula Bose
Mandira Varma-Basil
Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis
International Journal of Mycobacteriology
Efflux pumps
isoniazid resistance
Mycobacterium tuberculosis
author_facet Anshika Narang
Astha Giri
Shraddha Gupta
Kushal Garima
Mridula Bose
Mandira Varma-Basil
author_sort Anshika Narang
title Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis
title_short Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis
title_full Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis
title_fullStr Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis
title_full_unstemmed Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis
title_sort contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of mycobacterium tuberculosis
publisher Wolters Kluwer Medknow Publications
series International Journal of Mycobacteriology
issn 2212-5531
2212-554X
publishDate 2017-01-01
description Background: Isoniazid (INH) resistance in Mycobacterium tuberculosis has been mainly attributed to mutations in katG (64%) and inhA (19%). However, 20%–30% resistance to INH cannot be explained by mutations alone. Hence, other mechanisms besides mutations may play a significant role in providing drug resistance. Here, we explored the role of 24 putative efflux pump genes conferring INH-resistance in M. tuberculosis. Materials and Methods: Real-time expression profiling of the efflux pump genes was performed in five INH-susceptible and six high-level INH-resistant clinical isolates of M. tuberculosis exposed to the drug. Isolates were also analyzed for mutations in katG and inhA. Results: Four high-level INH-resistant isolates (minimum inhibitory concentration [MIC] ≥2.5 mg/L) with mutations at codon 315 (AGC-ACC) of katG showed upregulation of one of the efflux genes Rv1634, Rv0849, efpA, or p55. Another high-level INH-resistant isolate (MIC 1.5 mg/L), with no mutations at katG or inhA overexpressed 8/24 efflux genes, namely, Rv1273c, Rv0194, Rv1634, Rv1250, Rv3823c, Rv0507, jefA, and p55. Five of these, namely, Rv0194, Rv1634, Rv1250, Rv0507, and p55 were induced only in resistant isolates. Conclusion: The high number of efflux genes overexpressed in an INH-resistant isolate with no known INH resistance associated mutations, suggests a role for efflux pumps in resistance to this antituberculous agent, with the role of Rv0194 and Rv0507 in INH resistance being reported for the first time.
topic Efflux pumps
isoniazid resistance
Mycobacterium tuberculosis
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2017;volume=6;issue=2;spage=177;epage=183;aulast=Narang
work_keys_str_mv AT anshikanarang contributionofputativeeffluxpumpgenestoisoniazidresistanceinclinicalisolatesofmycobacteriumtuberculosis
AT asthagiri contributionofputativeeffluxpumpgenestoisoniazidresistanceinclinicalisolatesofmycobacteriumtuberculosis
AT shraddhagupta contributionofputativeeffluxpumpgenestoisoniazidresistanceinclinicalisolatesofmycobacteriumtuberculosis
AT kushalgarima contributionofputativeeffluxpumpgenestoisoniazidresistanceinclinicalisolatesofmycobacteriumtuberculosis
AT mridulabose contributionofputativeeffluxpumpgenestoisoniazidresistanceinclinicalisolatesofmycobacteriumtuberculosis
AT mandiravarmabasil contributionofputativeeffluxpumpgenestoisoniazidresistanceinclinicalisolatesofmycobacteriumtuberculosis
_version_ 1725350938656374784